A new set of useful cloning and expression vectors derived from pBlueScript

Area of Science:

• Molecular Biology
• Genetic Engineering

Background:

• The pBlueScript cloning vector is widely used but has limitations in selectable markers and copy number.
• Existing vectors may lack flexibility for diverse gene expression needs.

Purpose of the Study:

• To engineer novel cloning vectors with modified antibiotic resistance genes and origins of replication.
• To create vectors offering a range of plasmid copy numbers and compatibility for sequential selection.
• To incorporate an inducible expression cassette for controlled gene expression.

Main Methods:

• Modification of the pBlueScript vector by replacing the ampicillin-resistance gene with kanamycin or tetracycline resistance genes.
• Substitution of the high-copy-number origin of replication with pBR322 or P15A origins to achieve lower copy numbers.
• Insertion of an expression cassette utilizing the ara operon promoter and AraC regulator for inducible expression.

Main Results:

• Generation of eight new vectors with distinct drug resistance profiles (kanamycin/tetracycline) and copy numbers (low, medium, high).
• Demonstration of vector compatibility, allowing for sequential selection and replacement.
• Successful implementation of a tightly regulated, inducible system for high-level gene expression.

Conclusions:

• The new vectors provide enhanced flexibility in cloning and gene expression studies.
• These vectors facilitate precise control over gene expression levels and timing.
• The developed system supports efficient high-level expression of single or multiple genes within a single cell.